• Explore /
  • Poster
  • / <span>Association of adrenal metastases with outcomes in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab in the GETUG-AFU-26 NIVOREN phase II trial.</span>

Association of adrenal metastases with outcomes in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab in the GETUG-AFU-26 NIVOREN phase II trial.

Abstract Poster

Authors

null

Emilien Billon

Institut Paoli-Calmettes, Marseille, France

Emilien Billon , Cécile Dalban , Stephane Oudard , Christine Chevreau , Brigitte Laguerre , Philippe Barthélémy , Delphine Borchiellini , Lionnel Geoffrois , Sylvie Negrier , Florence Joly , Antoine Thiery-Vuillemin , Marine Gross-Goupil , Frederic Rolland , Frank Priou , Hakim Mahammedi , Florence Tantot , Bernard Escudier , Sylvie Chabaud , Laurence Albiges , Gwenaelle Gravis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03013335

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 348)

DOI

10.1200/JCO.2022.40.6_suppl.348

Abstract #

348

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Rohit K. Jain

First Author: Shao Zhimin

First Author: Douglas Adkins

First Author: Michael B. Atkins